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Ex vivo CTC culture
Peripheral blood (6mL) was obtained from the advanced breast cancer patient without chemotherapy and the blood was placed in an EDTA tube (BD). Inc.) and a pretreatment was conducted with a combination of heat-and proteolytic-induced epitope retrieval steps. After pretreatment, the primary antibody was added and revealed with a DAB substrate chromogen (Dako Cytomation). Then, the slides were counterstained and mounted. Images of tumor sections were acquired on a Leica microscope. Histological features and pathological diagnosis were made by a pathologist on the original hematoxylin and eosin (HE) stained slides.
RNA-sequencing
Clustering and sequencing (Novogene Experimental Department)
The clustering of the index-coded samples was performed on a cBot Cluster Generation System using TruSeq PE Cluster Kit v3-cBot-HS (Illumia) according to the manufacturer's instructions. After cluster generation, the library preparations were sequenced on an Illumina Hiseq platform and 125 bp/150 bp paired-end reads.
Data analysis
Quality control: Raw data (raw reads) of fastq format were firstly processed through in-house perl scripts. In this step, clean data (clean reads) were obtained by removing reads containing adapter, reads containing ploy-N and low quality reads from raw data. At the same time, Q20, Q30 and GC content the clean data were calculated. All the downstream analyses were based on the clean data with high quality.
Reads mapping to the reference genome
Reference genome and gene model annotation files were downloaded from genome website directly. Index of the reference genome was built using Hisat2 v2.0.5
and paired-end clean reads were aligned to the reference genome using Hisat2 v2.0.5.
We selected Hisat2 as the mapping tool for that Hisat2 can generate a database of splice junctions based on the gene model annotation file and thus a better mapping result than other non-splice mapping tools. Corrected P-value of 0.05 and absolute foldchange of 2 were set as the threshold for significantly differential expression.
Quantification of gene expression level
